Cryo Cell International (CCEL) Cash from Financing Activities (2011 - 2026)

Cryo Cell International (CCEL) has 16 years of Cash from Financing Activities data on file, last reported at -$740290.0 in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$740290.0, up 26.3% year-over-year; the trailing twelve-month figure through Feb 2026 was -$4.5 million (down 77.64% YoY), and the FY2025 annual result was -$4.7 million, down 384.64% from the prior year.
• Cash from Financing Activities climbed to -$740290.0 in Q1 2026 per CCEL's latest filing, from -$937340.0 in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $8.7 million in Q3 2022 and troughed at -$5.6 million in Q4 2022.
• A 5-year average of -$493508.2 and a median of -$772847.0 in 2023 frame the typical range for Cash from Financing Activities.
• On a YoY basis, Cash from Financing Activities climbed as much as 1217.08% in 2022 and fell as far as 1476.04% in 2022.
• A 5-year view of Cash from Financing Activities shows it stood at -$5.6 million in 2022, then surged by 72.32% to -$1.5 million in 2023, then surged by 56.0% to -$677821.0 in 2024, then plunged by 38.29% to -$937340.0 in 2025, then increased by 21.02% to -$740290.0 in 2026.
• Business Quant data shows CCEL's Cash from Financing Activities at -$740290.0 in Q1 2026, -$937340.0 in Q4 2025, and -$3.5 million in Q3 2025.